Qube Research & Technologies LTD In Med Pharmaceuticals Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 200 shares of INM stock, worth $52. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$52
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding INM
# of Institutions
19Shares Held
686KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ362KShares$94,0494.44% of portfolio
-
Armistice Capital, LLC New York, NY267KShares$69,4110.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.3KShares$7,3580.0% of portfolio
-
Two Sigma Securities, LLC New York, NY15.4KShares$4,0090.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.7KShares$3,3080.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $236K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...